January 10, 2023
Oxford Cancer Analytics is pioneering a new generation of blood based liquid biopsy tests for early cancer detection, and has announced the completion of an additional seed financing round, led by Eka Ventures, with participation from LifeArc, MegaRobo Technologies, Oxford Technology Management, and value-add individual investors.
Read the full article
7.15.2021
Imagine the day when all cancers can be cured - it’s the ultimate objective of cancer research. Yet according to the World Health Organisation, cancer accounted for nearly 10 million deaths, globally, in 2020 alone.
Read more
11.23.2020
KQ Labs, an accelerator programme focused on data-driven health, run by the Francis Crick Institute and now funded by LifeArc, has selected ten new start-ups for its third cohort.
Read more
3.15.2019
The overall winner of the £10,000 prize for the best idea in the All-Innovate contest was DECancer.AI, developed by a team from Jesus College. Their personalised diagnostic platform uses AI to detect early cancer through analysis of an affordable blood test, combined with personalised medical history of the patient, allowing early treatment and cure.
Read more
For press enquiries, interviews and requests to re-use content, please contact us
%20(1).svg)
